No doubt, bluebird! And this one is substantially more legit than anything I remember in years.
Most of the OTC plays are obviously hyped pumps until the traders bail, but it’s been a long time since we’ve seen such a legitimate private company reverse merge in with such stellar potential. It’s not like they’re just starting.
They have issued patents, a boatload more pending that have been in the pipeline for a long time already, a CEO with phenomenal credentials, a sister company with deep connections and experience, all leading to genuinely phenomenal potential!
Plus, they’ve been through numerous iterations of the Texatron already. For me, this just means that massive institutional money will be lining up to invest here when they uplist to a new exchange.
This should become a very exciting investment for the long haul!
Bullish